Related Experiment Video
Updated: Jul 19, 2026
07:25
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
[Therapy of chronic hepatitis C]
1Service de Gastroentérologie et d'Hépatologie, CHUV, Lausanne. Darius.Moradpour@chuv.ch
Praxis
|October 25, 2006
Summary
Hepatitis C virus (HCV) infection treatments are evolving. Current therapies offer limited success, but new antiviral strategies promise improved outcomes for chronic hepatitis C management.
Area of Science:
- Hepatology
- Virology
- Internal Medicine
Background:
- Hepatitis C virus (HCV) infection is a major global cause of liver disease.
- HCV leads to chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
- Effective management of HCV is crucial for public health.
Purpose of the Study:
- To review current therapies for chronic Hepatitis C virus infection.
- To discuss evolving treatment strategies for HCV.
- To highlight the importance of comprehensive HCV management.
Main Methods:
- Review of existing literature on Hepatitis C virus therapies.
- Analysis of sustained virologic response rates for standard treatments.
- Discussion of emerging antiviral approaches for HCV.
Main Results:
- Standard therapy (pegylated interferon-alpha and ribavirin) shows variable efficacy.
- Sustained virologic response rates are up to 40-50% for genotype 1 HCV.
- Response rates reach approximately 80% for genotypes 2 and 3 HCV.
Conclusions:
- Current standard therapies for Hepatitis C virus infection have limitations.
- Comprehensive management should consider disease progression cofactors.
- Novel antiviral strategies are anticipated to enhance future HCV treatment outcomes.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...